MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9
- Type
- Retraction
- Notice date
- 4/1/2021 0:00
- Journal
- European Review for Medical and Pharmacological Sciences
- Publisher
- Verduci Editore
- Notice DOI
- 10.26355/eurrev_202104_25533
- Original paper DOI
- 10.26355/eurrev_202009_22830